Document is current
Any future updates will be listed below
-
Authors
Jiao, Heng
Lin, Siyun
Gu, Jianmin
Jiang, Dongxian
Cui, Peng
Huang, Zhiliang
Fang, Yong
Wang, Hao
Lin, Miao
Tang, Han
Jiang, Tian
Lin, Guangyi
Zhang, Shaoyuan
Yin, Hao
Liang, Fei
Wang, Jingshu
Fan, Xuning
Qiu, Fujun
Yang, Yang
Li, Zhigang
Li, Bin
Xiang, Jiaqing
Leng, Xuefeng
Han, Yongtao
Li, Chengcheng
Ai, Luoyan
Hou, Yingyong
Wang, Guoqiang
Zhang, Zhihong
Cai, Shangli
Liu, Tianshu
Yin, Jun
Tan, Lijie
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb (CA209-6KP)
- License Information
-
More Information
Article History
Received: 7 February 2025
Accepted: 12 April 2025
First Online: 15 May 2025
Declarations
:
: The primary protocol and all amendments received approval from the Institutional Review Board (IRB) of Zhongshan Hospital affiliated with Fudan University (B2022-004R) and from the IRBs of each participating institution. The study was performed following the Declaration of Helsinki and adhered to international standards of good clinical practice.
: All sample collection procedures adhered to standard clinical protocols, and written informed consent was obtained prior to the sample collection.
: Lijie Tan reported that the study was funded by Bristol-Myers Squibb (CA209-6KP). The other authors declared no competing interest.
